{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:54:30Z","timestamp":1794354870193,"version":"4.9.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"no funding"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13054-016-1382-6","type":"journal-article","created":{"date-parts":[[2016,7,4]],"date-time":"2016-07-04T11:52:18Z","timestamp":1467633138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Acute kidney injury in critically ill cancer patients: an update"],"prefix":"10.1186","volume":"20","author":[{"given":"Norbert","family":"Lameire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,2]]},"reference":[{"key":"1382_CR1","doi-asserted-by":"crossref","unstructured":"Cosmai L, Porta C, Gallieni M, Perazella MA. Onco-nephrology: a decalogue. Nephrol Dial Transplant. 2016;31:515-519.","DOI":"10.1093\/ndt\/gfv320"},{"key":"1382_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1053\/j.ajkd.2015.04.042","volume":"66","author":"EP Cohen","year":"2015","unstructured":"Cohen EP, Krzesinski JM, Launay-Vacher V, Sprangers B. Onco-nephrology: core curriculum 2015. Am J Kidney Dis. 2015;66:869\u201383.","journal-title":"Am J Kidney Dis."},{"key":"1382_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/ckj\/sft135","volume":"7","author":"N Lameire","year":"2014","unstructured":"Lameire N. Nephrotoxicity of recent anti-cancer agents. Clin Kidney J. 2014;7:11\u201322.","journal-title":"Clin Kidney J."},{"key":"1382_CR4","doi-asserted-by":"crossref","unstructured":"Launay-Vacher V, Aapro M, De Castro G Jr, Cohen E, Deray G, Dooley M, Humphreys B, Lichtman S, Rey J, Scott\u00e9 F, Wildiers H, Sprangers B. Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN). Ann Oncol. 2015;26:1677\u201384.","DOI":"10.1093\/annonc\/mdv136"},{"key":"1382_CR5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.semnephrol.2015.01.004","volume":"35","author":"M Heung","year":"2015","unstructured":"Heung M, Koyner JL. Entanglement of sepsis, chronic kidney disease, and other comorbidities in patients who develop acute kidney injury. Semin Nephrol. 2015;35:23\u201337.","journal-title":"Semin Nephrol."},{"key":"1382_CR6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcrc.2011.06.014","volume":"27","author":"MM Rosolem","year":"2012","unstructured":"Rosolem MM, Rabello LS, Lisboa T, Caruso P, Costa RT, Leal JV, et al. Critically ill patients with cancer and sepsis: clinical course and prognostic factors. J Crit Care. 2012;27:301\u20137.","journal-title":"J Crit Care."},{"key":"1382_CR7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00277-015-2585-7","volume":"95","author":"SC Howard","year":"2016","unstructured":"Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol. 2016;95:563\u201373.","journal-title":"Ann Hematol."},{"key":"1382_CR8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.semnephrol.2010.09.009","volume":"30","author":"A Kogon","year":"2010","unstructured":"Kogon A, Hingorani S. Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol. 2010;30:615\u201326.","journal-title":"Semin Nephrol."},{"key":"1382_CR9","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/ndt\/gfh637","volume":"20","author":"DD Benoit","year":"2005","unstructured":"Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, et al. Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant. 2005;20:552\u20138.","journal-title":"Nephrol Dial Transplant."},{"key":"1382_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccc.2009.09.002","volume":"26","author":"DD Benoit","year":"2010","unstructured":"Benoit DD, Hoste EA. Acute kidney injury in critically ill patients with cancer. Crit Care Clin. 2010;26:151\u201379.","journal-title":"Crit Care Clin."},{"key":"1382_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055870","volume":"8","author":"E Canet","year":"2013","unstructured":"Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D, et al. Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS One. 2013;8, e55870.","journal-title":"PLoS One."},{"key":"1382_CR12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2215\/CJN.03530412","volume":"8","author":"AK Salahudeen","year":"2013","unstructured":"Salahudeen AK, Doshi SM, Pawar T, Nowshad G, Lahoti A, Shah P. Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center. Clin J Am Soc Nephrol. 2013;8:347\u201354.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1382_CR13","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nrneph.2015.81","volume":"11","author":"A Ganguli","year":"2015","unstructured":"Ganguli A, Sawinski D, Berns JS. Kidney diseases associated with haematological cancers. Nat Rev Nephrol. 2015;11:478\u201390.","journal-title":"Nat Rev Nephrol."},{"key":"1382_CR14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.ackd.2013.08.009","volume":"21","author":"N Leung","year":"2014","unstructured":"Leung N, Nasr SH. Myeloma-related kidney disease. Adv Chronic Kidney Dis. 2014;21:36\u201347.","journal-title":"Adv Chronic Kidney Dis."},{"key":"1382_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.ackd.2013.08.007","volume":"21","author":"D Sawinski","year":"2014","unstructured":"Sawinski D. The kidney effects of hematopoietic stem cell transplantation. Adv Chronic Kidney Dis. 2014;21:96\u2013105.","journal-title":"Adv Chronic Kidney Dis."},{"key":"1382_CR16","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1200\/JCO.2006.05.7869","volume":"24","author":"M Soares","year":"2006","unstructured":"Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N. Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol. 2006;24:4003\u201310.","journal-title":"J Clin Oncol."},{"key":"1382_CR17","unstructured":"Kidney Diseases Improving Global Outcomes: clinical practice guideline for acute kidney injury. Kidney Int. 2012; Suppl 2 (1):1\u2013138."},{"key":"1382_CR18","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1681\/ASN.2014070724","volume":"26","author":"JA Kellum","year":"2015","unstructured":"Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231\u20138.","journal-title":"J Am Soc Nephrol."},{"key":"1382_CR19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1053\/j.ajkd.2011.02.389","volume":"58","author":"Z Zhang","year":"2011","unstructured":"Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: a systemic review and meta-analysis. Am J Kidney Dis. 2011;58:356\u201365.","journal-title":"Am J Kidney Dis."},{"key":"1382_CR20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00467-004-1548-3","volume":"19","author":"E Bardi","year":"2004","unstructured":"Bardi E, Bobok I, Olah AV, Olah E, Kappelmayer J, Kiss C. Cystatin C is a suitable marker of glomerular function in children with cancer. Pediatr Nephrol. 2004;19:1145\u20137.","journal-title":"Pediatr Nephrol."},{"key":"1382_CR21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10157-010-0334-8","volume":"14","author":"T Okura","year":"2010","unstructured":"Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, et al. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol. 2010;14:584\u20138.","journal-title":"Clin Exp Nephrol."},{"key":"1382_CR22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2215\/CJN.12191213","volume":"10","author":"JL Alge","year":"2015","unstructured":"Alge JL, Arthur JM. Biomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications. Clin J Am Soc Nephrol. 2015;10:147\u201355.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1382_CR23","first-page":"359","volume":"29","author":"PD Carvalho","year":"2015","unstructured":"Carvalho PD, edo de Oliveira NF, Cavalcante MG, Pinheiro Gomes WG, da Costa Moraes CA, Costa Martins AM, et al. Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study. Pediatr Nephrol. 2015;29:359\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1382_CR24","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/pbc.25137","volume":"61","author":"E Ylinen","year":"2014","unstructured":"Ylinen E, Jahnukainen K, Saarinen-Pihkala UM, Jahnukainen T. Assessment of renal function during high-dose methotrexate treatment in children with acute lymphoblastic leukemia. Pediatr Blood Cancer. 2014;61:2199\u2013202.","journal-title":"Pediatr Blood Cancer."},{"key":"1382_CR25","doi-asserted-by":"crossref","first-page":"158658","DOI":"10.1155\/2015\/158658","volume":"2015","author":"M Bell","year":"2015","unstructured":"Bell M, Larsson A, Venge P, Bellomo R, Martensson J. Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury. Dis Markers. 2015;2015:158658.","journal-title":"Dis Markers."},{"key":"1382_CR26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ndt\/gfs380","volume":"28","author":"J Vanmassenhove","year":"2013","unstructured":"Vanmassenhove J, Vanholder R, Nagler E, Van BW. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transplant. 2013;28:254\u201373.","journal-title":"Nephrol Dial Transplant."},{"key":"1382_CR27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","volume":"382","author":"NH Lameire","year":"2013","unstructured":"Lameire NH, Bagga A, Cruz D, De MJ, Endre Z, Kellum JA, et al. Acute kidney injury: an increasing global concern. Lancet. 2013;382:170\u20139.","journal-title":"Lancet."},{"key":"1382_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.ackd.2013.09.002","volume":"21","author":"MA Perazella","year":"2014","unstructured":"Perazella MA, Berns JS, Rosner MH. Cancer and the kidney: the growth of onco-nephrology. Adv Chronic Kidney Dis. 2014;21:4\u20136.","journal-title":"Adv Chronic Kidney Dis."},{"key":"1382_CR29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1681\/ASN.2012070690","volume":"24","author":"AK Salahudeen","year":"2013","unstructured":"Salahudeen AK, Bonventre JV. Onconephrology: the latest frontier in the war against kidney disease. J Am Soc Nephrol. 2013;24:26\u201330.","journal-title":"J Am Soc Nephrol."},{"key":"1382_CR30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EA Hoste","year":"2015","unstructured":"Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411\u201323.","journal-title":"Intensive Care Med."},{"key":"1382_CR31","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2215\/CJN.04560514","volume":"10","author":"R Murugan","year":"2015","unstructured":"Murugan R, Wen X, Keener C, Pike F, Palevsky PM, Unruh M, et al. Associations between intensity of RRT, inflammatory mediators, and outcomes. Clin J Am Soc Nephrol. 2015;10:926\u201333.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1382_CR32","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00520-010-0978-7","volume":"19","author":"J Samuels","year":"2011","unstructured":"Samuels J, Ng CS, Nates J, Price K, Finkel K, Salahudeen A, et al. Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancer. Support Care Cancer. 2011;19:1527\u201332.","journal-title":"Support Care Cancer."},{"key":"1382_CR33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00134-014-3373-x","volume":"40","author":"M Vliet van","year":"2014","unstructured":"van Vliet M, Verburg IW, van den Boogaard M, de Keizer NF, Peek N, Blijlevens NM, et al. Trends in admission prevalence, illness severity and survival of haematological patients treated in Dutch intensive care units. Intensive Care Med. 2014;40:1275\u201384.","journal-title":"Intensive Care Med."},{"key":"1382_CR34","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/cc2870","volume":"8","author":"M Soares","year":"2004","unstructured":"Soares M, Fontes F, Dantas J, Gadelha D, Cariello P, Nardes F, et al. Performance of six severity-of-illness scores in cancer patients requiring admission to the intensive care unit: a prospective observational study. Crit Care. 2004;8:R194\u2013203.","journal-title":"Crit Care."},{"key":"1382_CR35","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc7713","volume":"13","author":"FS Taccone","year":"2009","unstructured":"Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13:R15.","journal-title":"Crit Care."},{"key":"1382_CR36","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","volume":"31","author":"E Azoulay","year":"2013","unstructured":"Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium\u2014a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique study. J Clin Oncol. 2013;31:2810\u20138.","journal-title":"J Clin Oncol."},{"key":"1382_CR37","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","volume":"29","author":"E Azoulay","year":"2015","unstructured":"Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M, et al. Managing critically ill hematology patients: Time to think differently. Blood Rev. 2015;29:359\u201367.","journal-title":"Blood Rev."},{"key":"1382_CR38","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s00134-014-3480-8","volume":"40","author":"DD Benoit","year":"2014","unstructured":"Benoit DD, Soares M, Azoulay E. Has survival increased in cancer patients admitted to the ICU? We are not sure. Intensive Care Med. 2014;40:1576\u20139.","journal-title":"Intensive Care Med."},{"key":"1382_CR39","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/ndt\/gfv372","volume":"30","author":"M Darmon","year":"2015","unstructured":"Darmon M, Vincent F, Canet E, Mokart D, Pene F, Kouatchet A, et al. Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Reanimation Respiratoire en Onco-Hematologie. Nephrol Dial Transplant. 2015;30:2006\u201313.","journal-title":"Nephrol Dial Transplant."},{"key":"1382_CR40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ndt\/gfq441","volume":"26","author":"E Maccariello","year":"2011","unstructured":"Maccariello E, Valente C, Nogueira L, Bonomo Jr H, Ismael M, Machado JE, et al. Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant. 2011;26:537\u201343.","journal-title":"Nephrol Dial Transplant."},{"key":"1382_CR41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00134-014-3615-y","volume":"41","author":"D Mokart","year":"2015","unstructured":"Mokart D, Darmon M, Resche-Rigon M, Lemiale V, Pene F, Mayaux J, et al. Prognosis of neutropenic patients admitted to the intensive care unit. Intensive Care Med. 2015;41:296\u2013303.","journal-title":"Intensive Care Med."},{"key":"1382_CR42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcrc.2014.01.014","volume":"29","author":"G Aygencel","year":"2014","unstructured":"Aygencel G, Turkoglu M, Turkoz SG, Benekli M. Prognostic factors in critically ill cancer patients admitted to the intensive care unit. J Crit Care. 2014;29:618\u201326.","journal-title":"J Crit Care."},{"key":"1382_CR43","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00277-014-2141-x","volume":"93","author":"P Wohlfarth","year":"2014","unstructured":"Wohlfarth P, Staudinger T, Sperr WR, Bojic A, Robak O, Hermann A, et al. Prognostic factors, long-term survival, and outcome of cancer patients receiving chemotherapy in the intensive care unit. Ann Hematol. 2014;93:1629\u201336.","journal-title":"Ann Hematol."},{"key":"1382_CR44","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5847\/wjem.j.issn.1920-8642.2012.04.007","volume":"3","author":"XZ Xing","year":"2012","unstructured":"Xing XZ, Wang HJ, Huang CL, Yang QH, Qu SN, Zhang H, et al. Two acute kidney injury risk scores for critically ill cancer patients undergoing non-cardiac surgery. World J Emerg Med. 2012;3:278\u201381.","journal-title":"World J Emerg Med."},{"key":"1382_CR45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/bja\/aer449","volume":"108","author":"GT Bird","year":"2012","unstructured":"Bird GT, Farquhar-Smith P, Wigmore T, Potter M, Gruber PC. Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5\u00a0yr study. Br J Anaesth. 2012;108:452\u20139.","journal-title":"Br J Anaesth."},{"key":"1382_CR46","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1002\/cncr.25306","volume":"116","author":"A Lahoti","year":"2010","unstructured":"Lahoti A, Kantarjian H, Salahudeen AK, Ravandi F, Cortes JE, Faderl S, et al. Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Cancer. 2010;116:4063\u20138.","journal-title":"Cancer."},{"key":"1382_CR47","first-page":"107. e1","volume":"26","author":"MR Park","year":"2011","unstructured":"Park MR, Jeon K, Song JU, Lim SY, Park SY, Lee JE, et al. Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit. J Crit Care. 2011;26:107. e1\u2013107.e6.","journal-title":"J Crit Care"},{"key":"1382_CR48","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1007\/s00134-010-1903-8","volume":"36","author":"DM Vandijck","year":"2010","unstructured":"Vandijck DM, Depuydt PO, Offner FC, Nollet J, Peleman RA, Steel E, et al. Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies. Intensive Care Med. 2010;36:1744\u201350.","journal-title":"Intensive Care Med."},{"key":"1382_CR49","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.4081\/rt.2014.5389","volume":"6","author":"AE Mirrakhimov","year":"2014","unstructured":"Mirrakhimov AE, Ali AM, Khan M, Barbaryan A. Tumor lysis syndrome in solid tumors: an up to date review of the literature. Rare Tumors. 2014;6:5389.","journal-title":"Rare Tumors."},{"key":"1382_CR50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5492\/wjccm.v4.i2.130","volume":"4","author":"AE Mirrakhimov","year":"2015","unstructured":"Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: a clinical review. World J Crit Care Med. 2015;4:130\u20138.","journal-title":"World J Crit Care Med."},{"key":"1382_CR51","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","volume":"149","author":"MS Cairo","year":"2010","unstructured":"Cairo MS, Coiffier B, Reiter A, Younes A. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol. 2010;149:578\u201386.","journal-title":"Br J Haematol."},{"key":"1382_CR52","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ackd.2013.07.001","volume":"21","author":"FP Wilson","year":"2014","unstructured":"Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis. 2014;21:18\u201326.","journal-title":"Adv Chronic Kidney Dis."},{"key":"1382_CR53","first-page":"3","volume":"12","author":"BD Humphreys","year":"2013","unstructured":"Humphreys BD, Sanders PW. Cancer and the kidney. NephSAP. 2013;12:3\u201364.","journal-title":"NephSAP."},{"key":"1382_CR54","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26:2767\u201378.","journal-title":"J Clin Oncol."},{"key":"1382_CR55","first-page":"23","volume":"10","author":"J Dinnel","year":"2015","unstructured":"Dinnel J, Moore BL, Skiver BM, Bose P. Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy. Core Evid. 2015;10:23\u201338.","journal-title":"Core Evid."},{"key":"1382_CR56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2013.02.378","volume":"62","author":"MA Lopez-Olivo","year":"2013","unstructured":"Lopez-Olivo MA, Pratt G, Palla SL, Salahudeen A. Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis. 2013;62:481\u201392.","journal-title":"Am J Kidney Dis."},{"key":"1382_CR57","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/annonc\/mdh362","volume":"15","author":"V Pitini","year":"2004","unstructured":"Pitini V, Bramanti P, Arrigo C, Sessa E, La GG, Amata C. Acute neurotoxicity as a serious adverse event related to rasburicase in a non-Hodgkin's lymphoma patient. Ann Oncol. 2004;15:1446.","journal-title":"Ann Oncol."},{"key":"1382_CR58","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/ejhg.2009.8","volume":"17","author":"TG Clark","year":"2009","unstructured":"Clark TG, Fry AE, Auburn S, Campino S, Diakite M, Green A, et al. Allelic heterogeneity of G6PD deficiency in West Africa and severe malaria susceptibility. Eur J Hum Genet. 2009;17:1080\u20135.","journal-title":"Eur J Hum Genet."},{"key":"1382_CR59","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1056\/NEJMc1106641","volume":"365","author":"JM Elinoff","year":"2011","unstructured":"Elinoff JM, Salit RB, Ackerman HC. The tumor lysis syndrome. N Engl J Med. 2011;365:571\u20132.","journal-title":"N Engl J Med."},{"key":"1382_CR60","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ajem.2010.12.029","volume":"30","author":"A El-Husseini","year":"2012","unstructured":"El-Husseini A, Sabucedo A, Lamarche J, Courville C, Peguero A. Acute kidney injury associated with tumor lysis syndrome: a paradigm shift. Am J Emerg Med. 2012;30:390\u20136.","journal-title":"Am J Emerg Med."},{"key":"1382_CR61","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2009.10.056","volume":"55","author":"AK Abu-Alfa","year":"2010","unstructured":"Abu-Alfa AK, Younes A. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Am J Kidney Dis. 2010;55:S1\u201313.","journal-title":"Am J Kidney Dis."},{"key":"1382_CR62","first-page":"494","volume":"23","author":"JT Kielstein","year":"2010","unstructured":"Kielstein JT, Schiffer M, Hafer C. Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit. J Nephrol. 2010;23:494\u2013501.","journal-title":"J Nephrol."},{"key":"1382_CR63","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2215\/CJN.02130309","volume":"4","author":"AK Salahudeen","year":"2009","unstructured":"Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, et al. Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol. 2009;4:1338\u201346.","journal-title":"Clin J Am Soc Nephrol."},{"key":"1382_CR64","doi-asserted-by":"crossref","first-page":"e0149706","DOI":"10.1371\/journal.pone.0149706","volume":"11","author":"V Torres da Costa E Silva","year":"2016","unstructured":"Torres da Costa E Silva V, Costalonga EC, Oliveira AP, Hung J, Caires RA, Hajjar LA, et al. Evaluation of intermittent hemodialysis in critically ill cancer patients with acute kidney injury using single-pass batch equipment. PLoS One. 2016;11:e0149706.","journal-title":"PLoS One"},{"key":"1382_CR65","first-page":"59","volume":"54","author":"M Agha-Razii","year":"2000","unstructured":"Agha-Razii M, Amyot SL, Pichette V, Cardinal J, Ouimet D, Leblanc M. Continuous veno-venous hemodiafiltration for the treatment of spontaneous tumor lysis syndrome complicated by acute renal failure and severe hyperuricemia. Clin Nephrol. 2000;54:59\u201363.","journal-title":"Clin Nephrol."},{"key":"1382_CR66","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/ndt\/gfr773","volume":"27","author":"CA Hutchison","year":"2012","unstructured":"Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, et al. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant. 2012;27:3823\u20138.","journal-title":"Nephrol Dial Transplant."},{"key":"1382_CR67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MNH.0000000000000101","volume":"24","author":"F Madore","year":"2015","unstructured":"Madore F. Plasmapheresis in cast nephropathy: yes or no? Curr Opin Nephrol Hypertens. 2015;24:177\u201382.","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"1382_CR68","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/ejh.12644","volume":"96","author":"P Yadav","year":"2016","unstructured":"Yadav P, Hutchison CA, Basnayake K, Stringer S, Jesky M, Fifer L, et al. Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury. Eur J Haematol. 2016;96:610\u20137.","journal-title":"Eur J Haematol."},{"key":"1382_CR69","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1056\/NEJMra1214243","volume":"371","author":"LS Chawla","year":"2014","unstructured":"Chawla LS, Eggers PW, Star RA, Kimmel PL. Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med. 2014;371:58\u201366.","journal-title":"N Engl J Med."},{"key":"1382_CR70","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.semnephrol.2010.09.010","volume":"30","author":"EP Cohen","year":"2010","unstructured":"Cohen EP, Pais P, Moulder JE. Chronic kidney disease after hematopoietic stem cell transplantation. Semin Nephrol. 2010;30:627\u201334.","journal-title":"Semin Nephrol."},{"key":"1382_CR71","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/bmt.2012.85","volume":"48","author":"T Shimoi","year":"2013","unstructured":"Shimoi T, Ando M, Munakata W, Kobayashi T, Kakihana K, Ohashi K, et al. The significant impact of acute kidney injury on CKD in patients who survived over 10\u00a0years after myeloablative allogeneic SCT. Bone Marrow Transplant. 2013;48:80\u20134.","journal-title":"Bone Marrow Transplant."},{"key":"1382_CR72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000334143","volume":"33","author":"SL Goldstein","year":"2012","unstructured":"Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif. 2012;33:131\u20137.","journal-title":"Blood Purif."},{"key":"1382_CR73","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1200\/JCO.2005.01.487","volume":"23","author":"G Thiery","year":"2005","unstructured":"Thiery G, Azoulay E, Darmon M, Ciroldi M, de Miranda S, Levy V, et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol. 2005;23:4406\u201313.","journal-title":"J Clin Oncol."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-016-1382-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:46:03Z","timestamp":1498326363000},"score":1,"resource":{"primary":{"URL":"http:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-016-1382-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,2]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1382"],"URL":"https:\/\/doi.org\/10.1186\/s13054-016-1382-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,2]]},"article-number":"209"}}